180 Life Sciences Corp.
ATNF
$0.83
-$0.037-4.27%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -2.37M | -4.27M | -836.70K | 11.80K | -1.07M |
| Total Depreciation and Amortization | -- | -3.10K | 13.90K | 24.00K | 23.60K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 577.60K | 2.82M | -20.80K | -134.90K | 236.30K |
| Change in Net Operating Assets | 937.90K | 509.80K | 620.00K | 826.30K | -223.50K |
| Cash from Operations | -853.70K | -950.70K | -223.70K | 727.20K | -1.03M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -3.30K | -327.60K | -476.10K | -264.90K | -264.90K |
| Issuance of Common Stock | -- | 5.37M | 0.00 | 0.00 | 500.00 |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -3.30K | 5.04M | -476.10K | -264.90K | -264.40K |
| Foreign Exchange rate Adjustments | -3.60K | 297.80K | -251.60K | 8.00K | -2.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -860.60K | 4.39M | -951.40K | 470.30K | -1.30M |